Maximize merger arbitrage growth returns
Out maneuver the market and identify potential regulatory hurdles for mergers and acquisitions with MLex. Our exclusive market insight, analysis and commentary covers deals from pre-notification through notification, review and approval.
The world's leading hedge funds use the MLex DealRisk service to analyze deals through notification, review, approval and compliance with daily case updates on M&A clearance.
As reported first by MLex
Like to read the full text of these, or any other MLex insights? Request a trial subscription via the form at the bottom of the page.
DuPont, FMC asset-swap deal attracts EU concerns
Bayer-Monsanto US review hasn't resulted in remedy discussions yet
Bayer, Monsanto deal faces in-depth scrutiny in China as Phase 2 review begins
Our coverage includes exclusive insight and analysis on the following key deals around the globe.
Meet our global experts
Below is a small selection of our Mergers & Acquisitions editorial experts. See our complete contributor list for more.
Looking for breaking news and to review regulatory implications for specific deals? Complete the form to request a free, limited trial to MLex.